Clarity in development. Confidence in execution. Clearance on time.
I turn MedTech and diagnostic technologies into fundable, submission-ready systems — aligning technical, operational, and regulatory strategies early to prevent rework, accelerate readiness, and protect capital.
My approach fixes the core problem
Most MedTech programs don’t fail in testing. They fail in translation. By building the systems that align every function before they break, I have helped startups and growth-stage companies reduce time-to-market by up to 40%, cut costs by 25%, and raise over $350M in collective investment and acquisition value.
What we do
Building the systems that turn innovation into clearance
We embed within your organization to align technical, operational, and regulatory strategies from concept through commercialization. Our approach eliminates friction between functions and creates the clarity required for confident, audit-ready execution.
Latest Insights
Early Design Controls Don’t Slow You Down. Misused Ones Do
There is a persistent belief that early design controls are bureaucratic overhead that slow innovation. The reality is that early design controls should be used as a decision system. When applied well, they reduce rework, stabilize execution, and surface risk earlier. When applied poorly, they do exactly what critics complain about. This tension is not…
Diagnostic Risk: Is Not About Whether the Device Works – It’s About Whether the Answer Can Be Trusted
Diagnostic Risk: It’s Not About Whether the Device Works — It’s About Whether the Answer Can Be Trusted Did you know that in medical technologies, especially in vitro diagnostics, the most serious risk is not device failure, but credible wrong answers? This distinction separates medical technologies from biotechnology in a fundamental way. In biotech, failure…